Takeda Pharmaceutical Co., Ltd. (TAK)
18.46
+0.09
(+0.49%)
USD |
NYSE |
Feb 13, 16:00
18.55
+0.09
(+0.49%)
After-Hours: 20:00
Takeda Pharmaceutical Shareholders Equity (Quarterly) : 48.76B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 503.92M |
| Protagonist Therapeutics, Inc. | 645.44M |
| Nxera Pharma Co., Ltd. | 389.15M |
| PeptiDream Inc. | 356.14M |
| Stemcell Holdings, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.30B |
| Total Liabilities (Quarterly) | 49.54B |
| Debt to Equity Ratio | 0.635 |
| Current Ratio | 1.194 |
| Net Debt Paydown Yield | 1.77% |